Related references
Note: Only part of the references are listed.A randomized controlled trial of resistance and endurance exercise in amyotrophic lateral sclerosis
Lora L. Clawson et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2018)
Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?
N. W. Galwey
STATISTICS IN MEDICINE (2017)
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Robert Kueffner et al.
NATURE BIOTECHNOLOGY (2015)
The PRO-ACT database Design, initial analyses, and predictive features
Nazem Atassi et al.
NEUROLOGY (2014)
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
Koji Abe et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials
Brian P. Hobbs et al.
BIOMETRICS (2011)
ALS clinical trials Do enrolled patients accurately represent the ALS population?
A. Chio et al.
NEUROLOGY (2011)
Rethinking pragmatic randomised controlled trials: introducing the cohort multiple randomised controlled trial design
Clare Relton et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
The natural history of ALS is changing: Improved survival
Muddasir Qureshi et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Design of phase II ALS clinical trials
David A. Schoenfeld et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Trial of celecoxib in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
ANNALS OF NEUROLOGY (2006)
Share Paper
